R L Hebert1, J P Bent. 1. Division of Otolaryngology, Medical College of Georgia, Augusta, USA. RLHII@WORDNET.ATT.NET
Abstract
OBJECTIVE: To create a consensus of outcomes of pediatric functional endoscopic sinus surgery (FESS) and assess its effectiveness and safety. STUDY DESIGN: A meta-analysis of the literature on outcomes of pediatric FESS. METHODS: A meta-analysis of the literature was performed focusing on the number of patients per study, length of follow-up, prospective versus retrospective, and the separation or exclusion of patients with significant underlying systemic diseases (cystic fibrosis and immunodeficiencies). A rating scale based on the above criteria was used to select articles for inclusion. RESULTS: Eight published articles (832 patients) plus unpublished data from the authors' institution (50 patients) were included. The "positive" outcome rates for published, unpublished, and combined data were 88.4%, 92%, and 88.7%, respectively. No statistically significant differences in "positive" outcome existed between all published or unpublished series using a chi-squared test (power = .51, P = .38). The average combined follow-up was 3.7 years, with a major complication rate of 0.6%. CONCLUSION: Pediatric FESS is a safe and effective treatment for chronic sinusitis that is refractory to medical therapy.
OBJECTIVE: To create a consensus of outcomes of pediatric functional endoscopic sinus surgery (FESS) and assess its effectiveness and safety. STUDY DESIGN: A meta-analysis of the literature on outcomes of pediatric FESS. METHODS: A meta-analysis of the literature was performed focusing on the number of patients per study, length of follow-up, prospective versus retrospective, and the separation or exclusion of patients with significant underlying systemic diseases (cystic fibrosis and immunodeficiencies). A rating scale based on the above criteria was used to select articles for inclusion. RESULTS: Eight published articles (832 patients) plus unpublished data from the authors' institution (50 patients) were included. The "positive" outcome rates for published, unpublished, and combined data were 88.4%, 92%, and 88.7%, respectively. No statistically significant differences in "positive" outcome existed between all published or unpublished series using a chi-squared test (power = .51, P = .38). The average combined follow-up was 3.7 years, with a major complication rate of 0.6%. CONCLUSION: Pediatric FESS is a safe and effective treatment for chronic sinusitis that is refractory to medical therapy.
Authors: G Strauss; S Schaller; B Zaminer; S Heininger; M Hofer; D Manzey; J Meixensberger; A Dietz; T C Lüth Journal: HNO Date: 2011-05 Impact factor: 1.284
Authors: James G Krings; Dorina Kallogjeri; Andre Wineland; Kenneth G Nepple; Jay F Piccirillo; Anne E Getz Journal: Laryngoscope Date: 2013-10-09 Impact factor: 3.325